Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients With mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients With Metastatic Renal Cell Carcinoma. Results From a Multi-Institutional Registry (REMARCC)
Eur Urol Oncol 2020 Dec 28;[EPub Ahead of Print], M Marchioni, M Kriegmair, M Heck, T Amiel, F Porpiglia, E Ceccucci, R Campi, A Minervini, A Mari, S Van Bruwaene, E Linares, V Hevia, M Musquera, M D'Anna, I Derweesh, A Bradshaw, R Autorino, G Guruli, A Veccia, E Roussel, M Albersen, N Pavan, F Claps, A Antonelli, C Palumbo, T Klatte, S Erdem, MC MirFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.